Czech downstream oil group Unipetrol said it was prepared to raise its stake in Ceska Rafinerska if one the refinery's two other shareholders were to exit, it said in its 2010 annual report.
It said it would do so if the economic terms were justified.
Unipetrol had said earlier this month that it was informed that Italy's Eni is in talks with Russia's Gazprom to sell its nearly 33% stake in Ceska Rafinerska.
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.
